Biologic agents added to non-surgical periodontal therapy for intrabony defects
Official title: Evaluation of the Efficacy of rhPDGF, L-PRF and EMD as an Adjunct to Non-surgical Periodontal Therapy of Intrabony Defects: a Randomized Controlled Clinical Trial
Run by G. d'Annunzio University · NCT05858411 · Data updated 2026-11-12
This study tests whether adding rhPDGF, L-PRF, or enamel matrix derivatives to minimally invasive non-surgical therapy helps restore deep bone defects in periodontitis patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 88 (estimated) |
| Sponsor | G. d'Annunzio University Academic / other |
| Locations | 1 site (Tirana) |
| Status | Recruiting |
| Started | January 8, 2023 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT05858411 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with stage III–IV periodontitis, non-smokers or former smokers quit for at least 1 year, with at least one infrabony defect (PPD ≥ 5 mm, defect depth ≥ 3 mm) and no recent periodontal treatment.
✕Probably not a fit
Patients with three-wall infrabony defects, uncontrolled systemic conditions, recent antibiotic therapy, or ongoing orthodontic treatment may not see additional benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized clinical trial will compare four treatment approaches over 12 months in patients with infrabony defects due to periodontitis. Participants will be allocated to MINST alone, MINST with rhPDGF, MINST with L-PRF, or MINST with enamel matrix derivatives, with each defect treated under local anesthesia using ultrasonic and hand instrumentation. Outcomes will be assessed clinically and radiographically to determine relative effectiveness in attachment gain and defect fill. The study aims to determine if adding biologic or regenerative agents to MINST provides additional benefits over MINST alone.
Why it matters
Potential benefit: If successful, patients could experience greater pocket depth reduction and attachment gain with certain biologic adjuncts to MINST.
How similar studies have gone: Prior regenerative approaches in periodontal defects have shown variable improvements; this study tests multiple adjuncts against MINST alone to identify potential advantages.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a diagnosis of periodontitis stage III or IV (grades A to C), * non-smokers or former smokers who quit at least 1 year ago, and * had not received any periodontal treatment in the 3 months prior to recruitment; * Presence of at least 1 Infrabony defect (PPD ≥ 5 mm with infrabony defect depth of ≥3mm at screening radiograph); * One and two wall infrabony defects at screening radiograph and periodontal charting. * Signed informed consent. Exclusion Criteria: * Presence of uncontrolled systemic diseases that could affect treatment outcomes such as diabetes mellitus with an HbA1C\>7%, rheumatoid arthritis or any form of immunosuppression; * Subjects requiring antibiotic prophylaxis; * 3-wall infrabony defects; * Patients that had received systemic or local delivery of antibiotic therapy 6 weeks before enrollment; * Presence of furcation defect; * Chronic intake of NSAIDs or steroids, currently; * Patients undergoing orthodontic treatment, having removable prosthetic appliances, pregnancy, tumors of the oral cavity or the presence of any psychiatric condition that could affect participation.
Where it's running
-
University of Medicine of Tirana
Tirana, Albania Recruiting
Study contacts
- Study coordinator: Michele Paolantonio, DDS, MD
- Email: michelepaolantonio@gmail.com
- Phone: 3395204073
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
JAK1 and JAK2 activation in healthy versus inflamed gums
We will test whether the JAK1 and JAK2 immune-signaling pathways are more active in adults with periodontitis than in adults with healthy gums.
-
Using injectable platelet-rich fibrin with bovine bone grafts to treat intrabony periodontal defects
This will try adding injectable platelet-rich fibrin (i-PRF) to bovine bone grafts to see if adults with stage III periodontitis and intrabony defects heal better than with grafts alone.
-
Treatment of gum defects using hyaluronic acid and polynucleotides
This study is testing if adding a special gel to gum surgery helps people with gum disease heal better and faster.
-
Closed Surgical Technique vs Modified Papilla Preservation Technique in treating interdental periodontal defects
This trial tests whether the closed surgical technique with i-PRF can improve healing for isolated interdental periodontal defects better than the modified papilla preservation technique with i-PRF in adults.
-
Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease
This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.
-
Bacterial Diversity in Gum Health With Fixed vs Removable Retainers After Braces
This study tests the gum microbiome and gum health in adults after braces, comparing fixed lingual retainers to removable Essix retainers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.